DEDALUS HEALTHCARE FRANCE : revenue, balance sheet and financial ratios

DEDALUS HEALTHCARE FRANCE is a French company founded 28 years ago, specialized in the sector Tierce maintenance de systèmes et d’applications informatiques. Based in ARTIGUES-PRES-BORDEAUX (33370), this company of category ETI shows in 2024 a revenue of 127.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - DEDALUS HEALTHCARE FRANCE (SIREN 414599589)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2015
Revenue 127 853 817 € 98 898 479 € 95 969 194 € 78 538 057 € 52 513 693 € 65 665 682 € 74 141 091 € 78 661 320 € 77 398 110 €
Net income -3 339 445 € -3 020 526 € 2 309 808 € 9 235 215 € 6 352 610 € 1 121 259 € 4 115 404 € 2 710 974 € 3 582 357 €
EBITDA -144 612 € 2 001 740 € 7 992 868 € 8 357 944 € -1 532 636 € -20 870 313 € -20 481 705 € -22 287 457 € -24 585 896 €
Net margin -2.6% -3.1% 2.4% 11.8% 12.1% 1.7% 5.6% 3.4% 4.6%

Revenue and income statement

In 2024, DEDALUS HEALTHCARE FRANCE achieves revenue of 127.9 M€. Over the period 2015-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.7%. Vs 2023, growth of +29% (98.9 M€ -> 127.9 M€). After deducting consumption (0 €), gross margin stands at 127.9 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -145 k€, representing -0.1% of revenue. Warning negative scissor effect: despite revenue change (+29%), EBITDA varies by -107%, reducing margin by 2.1 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -3.3 M€ (-2.6% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

127 853 817 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

127 853 817 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-144 612 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-1 776 212 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-3 339 445 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-0.1%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 61%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 23.8 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 1.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

61.164%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

24.703%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

1.311%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

23.795

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

15.8%

Solvency indicators evolution
DEDALUS HEALTHCARE FRANCE

Sector positioning

Debt ratio
61.16 2024
2022
2023
2024
Q1: 0.0
Med: 6.26
Q3: 31.65
Average +32 pts over 3 years

In 2024, the debt ratio of DEDALUS HEALTHCARE FRANCE (61.16) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
24.7% 2024
2022
2023
2024
Q1: 10.26%
Med: 37.66%
Q3: 64.72%
Average -22 pts over 3 years

In 2024, the financial autonomy of DEDALUS HEALTHCARE FRANCE (24.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
23.8 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.37 years
Watch +16 pts over 3 years

In 2024, the repayment capacity of DEDALUS HEALTHCARE FRANCE (23.80) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 97.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

97.224

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-2123.12

Liquidity indicators evolution
DEDALUS HEALTHCARE FRANCE

Sector positioning

Liquidity ratio
97.22 2024
2022
2023
2024
Q1: 148.11
Med: 236.84
Q3: 413.51
Watch -8 pts over 3 years

In 2024, the liquidity ratio of DEDALUS HEALTHCARE FRANCE (97.22) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
-2123.12x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 1.49x
Watch -73 pts over 3 years

In 2024, the interest coverage of DEDALUS HEALTHCARE FRANCE (-2123.1x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 193 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 383 days. Excellent situation: suppliers finance 190 days of the operating cycle (retail model). Inventory turnover is 2 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 162 days of revenue, i.e. 57.5 M€ to permanently finance. Over 2015-2024, WCR increased by +116%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

57 479 241 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

193 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

383 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

2 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

162 j

WCR and payment terms evolution
DEDALUS HEALTHCARE FRANCE

Positioning of DEDALUS HEALTHCARE FRANCE in its sector

Comparison with sector Tierce maintenance de systèmes et d’applications informatiques

Valuation estimate

Based on 215 transactions of similar company sales (all years), the value of DEDALUS HEALTHCARE FRANCE is estimated at 20 522 282 € (range 11 008 157€ - 37 487 117€). The price/revenue ratio is 0.16x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
215 transactions
11008k€ 20522k€ 37487k€
20 522 282 € Range: 11 008 157€ - 37 487 117€
NAF 5 all-time

Valuation method used

Revenue Multiple
127 853 817 € × 0.16x = 20 522 282 €
Range: 11 008 157€ - 37 487 117€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Tierce maintenance de systèmes et d’applications informatiques)

Compare DEDALUS HEALTHCARE FRANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Tierce maintenance de systèmes et d’applications informatiques

Frequently asked questions about DEDALUS HEALTHCARE FRANCE

What is the revenue of DEDALUS HEALTHCARE FRANCE ?

The revenue of DEDALUS HEALTHCARE FRANCE in 2024 is 127.9 M€.

Is DEDALUS HEALTHCARE FRANCE profitable?

DEDALUS HEALTHCARE FRANCE recorded a net loss in 2024.

Where is the headquarters of DEDALUS HEALTHCARE FRANCE ?

The headquarters of DEDALUS HEALTHCARE FRANCE is located in ARTIGUES-PRES-BORDEAUX (33370), in the department Gironde.

Where to find the tax return of DEDALUS HEALTHCARE FRANCE ?

The tax return of DEDALUS HEALTHCARE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does DEDALUS HEALTHCARE FRANCE operate?

DEDALUS HEALTHCARE FRANCE operates in the sector Tierce maintenance de systèmes et d’applications informatiques (NAF code 62.02B). See the 'Sector positioning' section above to compare the company with its competitors.